The market is driven by the increase in infectious diseases. In addition, increasing clinical trials in countries is anticipated to boost the growth of the bioprocess technology market.
The prevalence of infectious diseases is increasing at a faster rate due to the growing global population. In addition, the rapid spread of global pandemics such as Ebola, SARS, swine flu, Zika, and Lassa fever created high demand for vaccines and drugs to treat the cause. This led to the R&D of antiviral drugs, cell-based therapies, and vaccines using cell culture methods. For instance, in July 2021, Cytiva and Pall Corp. announced its capacity expansion plan to increase the manufacture of key products used to make biologic medicines. New sites are opening in the US and the UK to address regional manufacturing models. Many such investments are expected to drive the growth of the global bioprocess technology market during the forecast period.
Vendor Landscape:
The global bioprocess technology market is fragmented due to the presence of several well-established players. Major players are focusing on investing in R&D to develop new products. Vendors are also involved in M&A to gain a competitive edge in the market. The immense growth opportunities in the market, which include the application of bioprocess biotechnology, will increase competition among vendors.
Technavio identifies the following as the key players in the market:
- Advanced Instruments LLC
- Becton Dickinson and Co.
- Boehringer Ingelheim International GmbH
- Catalent Inc.
- Charles River Laboratories International Inc.
- Corning Inc.
- Dover Corp.
- Emerson Electric Co.
- Fujifilm Diosynth Biotechnologies USA Inc.
- General Electric Co.
- Koninklijke Philips NV
- Lonza Group Ltd.
- Merck KGaA
- Nova Biomedical Corp.
- Repligen Corp.
- Sartorius AG
- STADA Arzneimittel AG
- Thermo Fisher Scientific Inc.
- Univercells SA
- Eppendorf AG
The report segments the global bioprocess technology market by end-user (biopharmaceutical companies, contract manufacturing organizations, academic research institutes, and others) and geography (North America, Europe, Asia, and Rest of World (ROW)).
Bioprocess Technology Market End-user Outlook (Revenue, USD bn, 2021-2026)
- Biopharmaceutical companies - size and forecast 2021-2026
- Contract manufacturing organizations - size and forecast 2021-2026
- Academic research institute - size and forecast 2021-2026
- Others - size and forecast 2021-2026
Bioprocess Technology Market Geography Outlook (Revenue, USD bn, 2021-2026)
- North America - size and forecast 2021-2026
- Europe - size and forecast 2021-2026
- Asia - size and forecast 2021-2026
- Rest of World (ROW) - size and forecast 2021-2026
Technavio's sample reports are free of charge and contain multiple sections of the report, such as the market size and forecast, drivers, challenges, trends, and more. Request Sample Report Here
Related Reports:
Bioprocess Technology Market Scope |
Report Coverage |
Details |
Page number |
120 |
Base year |
2021 |
Forecast period |
2022-2026 |
Growth momentum & CAGR |
Accelerate at a CAGR of 12.27% |
Market growth 2022-2026 |
USD 55.84 billion |
Market structure |
Fragmented |
YoY growth (%) |
11.69 |
Regional analysis |
North America, Europe, Asia, and Rest of World (ROW) |
Performing market contribution |
North America at 42% |
Key consumer countries |
US, Germany, UK, France, and China |
Competitive landscape |
Leading companies, competitive strategies, consumer engagement scope |
Companies profiled |
Advanced Instruments LLC, Becton Dickinson and Co., Boehringer Ingelheim International GmbH, Catalent Inc., Charles River Laboratories International Inc., Corning Inc., Dover Corp., Emerson Electric Co., Fujifilm Diosynth Biotechnologies USA Inc., General Electric Co., Koninklijke Philips NV, Lonza Group Ltd., Merck KGaA, Nova Biomedical Corp., Repligen Corp., Sartorius AG, STADA Arzneimittel AG, Thermo Fisher Scientific Inc., Univercells SA, and Eppendorf AG |
Market Dynamics |
Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and future consumer dynamics, and market condition analysis for the forecast period. |
Customization purview |
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
Table of Contents:
1 Executive Summary
- 1.1 Market overview
- Exhibit 01: Executive Summary – Chart on Market Overview
- Exhibit 02: Executive Summary – Data Table on Market Overview
- Exhibit 03: Executive Summary – Chart on Global Market Characteristics
- Exhibit 04: Executive Summary – Chart on Market by Geography
- Exhibit 05: Executive Summary – Chart on Market Segmentation by End-user
- Exhibit 06: Executive Summary – Chart on Incremental Growth
- Exhibit 07: Executive Summary – Data Table on Incremental Growth
- Exhibit 08: Executive Summary – Chart on Vendor Market Positioning
2 Market Landscape
- 2.1 Market ecosystem
- Exhibit 09: Parent market
- Exhibit 10: Market Characteristics
3 Market Sizing
- 3.1 Market definition
- Exhibit 11: Offerings of vendors included in the market definition
- 3.2 Market segment analysis
- Exhibit 12: Market segments
- 3.4 Market outlook: Forecast for 2021-2026
- Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ billion)
- Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ billion)
- Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
- Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
4 Five Forces Analysis
- 4.1 Five forces summary
- Exhibit 17: Five forces analysis - Comparison between 2021 and 2026
- 4.2 Bargaining power of buyers
- Exhibit 18: Chart on Bargaining power of buyers – Impact of key factors 2021 and 2026
- 4.3 Bargaining power of suppliers
- Exhibit 19: Bargaining power of suppliers – Impact of key factors in 2021 and 2026
- 4.4 Threat of new entrants
- Exhibit 20: Threat of new entrants – Impact of key factors in 2021 and 2026
- 4.5 Threat of substitutes
- Exhibit 21: Threat of substitutes – Impact of key factors in 2021 and 2026
- 4.6 Threat of rivalry
- Exhibit 22: Threat of rivalry – Impact of key factors in 2021 and 2026
- 4.7 Market condition
- Exhibit 23: Chart on Market condition - Five forces 2021 and 2026
5 Market Segmentation by End-user
- 5.1 Market segments
- Exhibit 24: Chart on End-user - Market share 2021-2026 (%)
- Exhibit 25: Data Table on End-user - Market share 2021-2026 (%)
- 5.2 Comparison by End-user
- Exhibit 26: Chart on Comparison by End-user
- Exhibit 27: Data Table on Comparison by End-user
- 5.3 Biopharmaceutical companies - Market size and forecast 2021-2026
- Exhibit 28: Chart on Biopharmaceutical companies - Market size and forecast 2021-2026 ($ billion)
- Exhibit 29: Data Table on Biopharmaceutical companies - Market size and forecast 2021-2026 ($ billion)
- Exhibit 30: Chart on Biopharmaceutical companies - Year-over-year growth 2021-2026 (%)
- Exhibit 31: Data Table on Biopharmaceutical companies - Year-over-year growth 2021-2026 (%)
- 5.4 Contract manufacturing organizations - Market size and forecast 2021-2026
- Exhibit 32: Chart on Contract manufacturing organizations - Market size and forecast 2021-2026 ($ billion)
- Exhibit 33: Data Table on Contract manufacturing organizations - Market size and forecast 2021-2026 ($ billion)
- Exhibit 34: Chart on Contract manufacturing organizations - Year-over-year growth 2021-2026 (%)
- Exhibit 35: Data Table on Contract manufacturing organizations - Year-over-year growth 2021-2026 (%)
- 5.5 Academic research institute - Market size and forecast 2021-2026
- Exhibit 36: Chart on Academic research institute - Market size and forecast 2021-2026 ($ billion)
- Exhibit 37: Data Table on Academic research institute - Market size and forecast 2021-2026 ($ billion)
- Exhibit 38: Chart on Academic research institute - Year-over-year growth 2021-2026 (%)
- Exhibit 39: Data Table on Academic research institute - Year-over-year growth 2021-2026 (%)
- 5.6 Others - Market size and forecast 2021-2026
- Exhibit 40: Chart on Others - Market size and forecast 2021-2026 ($ billion)
- Exhibit 41: Data Table on Others - Market size and forecast 2021-2026 ($ billion)
- Exhibit 42: Chart on Others - Year-over-year growth 2021-2026 (%)
- Exhibit 43: Data Table on Others - Year-over-year growth 2021-2026 (%)
- 5.7 Market opportunity by End-user
- Exhibit 44: Market opportunity by End-user ($ billion)
6 Customer Landscape
- 6.1 Customer landscape overview
- Exhibit 45: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
7 Geographic Landscape
- 7.1 Geographic segmentation
- Exhibit 46: Chart on Market share by geography 2021-2026 (%)
- Exhibit 47: Data Table on Market share by geography 2021-2026 (%)
- 7.2 Geographic comparison
- Exhibit 48: Chart on Geographic comparison
- Exhibit 49: Data Table on Geographic comparison
- 7.3 North America - Market size and forecast 2021-2026
- Exhibit 50: Chart on North America - Market size and forecast 2021-2026 ($ billion)
- Exhibit 51: Data Table on North America - Market size and forecast 2021-2026 ($ billion)
- Exhibit 52: Chart on North America - Year-over-year growth 2021-2026 (%)
- Exhibit 53: Data Table on North America - Year-over-year growth 2021-2026 (%)
- 7.4 Europe - Market size and forecast 2021-2026
- Exhibit 54: Chart on Europe - Market size and forecast 2021-2026 ($ billion)
- Exhibit 55: Data Table on Europe - Market size and forecast 2021-2026 ($ billion)
- Exhibit 56: Chart on Europe - Year-over-year growth 2021-2026 (%)
- Exhibit 57: Data Table on Europe - Year-over-year growth 2021-2026 (%)
- 7.5 Asia - Market size and forecast 2021-2026
- Exhibit 58: Chart on Asia - Market size and forecast 2021-2026 ($ billion)
- Exhibit 59: Data Table on Asia - Market size and forecast 2021-2026 ($ billion)
- Exhibit 60: Chart on Asia - Year-over-year growth 2021-2026 (%)
- Exhibit 61: Data Table on Asia - Year-over-year growth 2021-2026 (%)
- 7.6 Rest of World (ROW) - Market size and forecast 2021-2026
- Exhibit 62: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ billion)
- Exhibit 63: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ billion)
- Exhibit 64: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
- Exhibit 65: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
- 7.7 US - Market size and forecast 2021-2026
- Exhibit 66: Chart on US - Market size and forecast 2021-2026 ($ billion)
- Exhibit 67: Data Table on US - Market size and forecast 2021-2026 ($ billion)
- Exhibit 68: Chart on US - Year-over-year growth 2021-2026 (%)
- Exhibit 69: Data Table on US - Year-over-year growth 2021-2026 (%)
- 7.8 Germany - Market size and forecast 2021-2026
- Exhibit 70: Chart on Germany - Market size and forecast 2021-2026 ($ billion)
- Exhibit 71: Data Table on Germany - Market size and forecast 2021-2026 ($ billion)
- Exhibit 72: Chart on Germany - Year-over-year growth 2021-2026 (%)
- Exhibit 73: Data Table on Germany - Year-over-year growth 2021-2026 (%)
- 7.9 UK - Market size and forecast 2021-2026
- Exhibit 74: Chart on UK - Market size and forecast 2021-2026 ($ billion)
- Exhibit 75: Data Table on UK - Market size and forecast 2021-2026 ($ billion)
- Exhibit 76: Chart on UK - Year-over-year growth 2021-2026 (%)
- Exhibit 77: Data Table on UK - Year-over-year growth 2021-2026 (%)
- 7.10 France - Market size and forecast 2021-2026
- Exhibit 78: Chart on France - Market size and forecast 2021-2026 ($ billion)
- Exhibit 79: Data Table on France - Market size and forecast 2021-2026 ($ billion)
- Exhibit 80: Chart on France - Year-over-year growth 2021-2026 (%)
- Exhibit 81: Data Table on France - Year-over-year growth 2021-2026 (%)
- 7.11 China - Market size and forecast 2021-2026
- Exhibit 82: Chart on China - Market size and forecast 2021-2026 ($ billion)
- Exhibit 83: Data Table on China - Market size and forecast 2021-2026 ($ billion)
- Exhibit 84: Chart on China - Year-over-year growth 2021-2026 (%)
- Exhibit 85: Data Table on China - Year-over-year growth 2021-2026 (%)
- 7.12 Market opportunity by geography
- Exhibit 86: Market opportunity by geography ($ billion)
8 Drivers, Challenges, and Trends
- 8.3 Impact of drivers and challenges
- Exhibit 87: Impact of drivers and challenges in 2021 and 2026
9 Vendor Landscape
- 9.2 Vendor landscape
- Exhibit 88: Overview on Criticality of inputs and Factors of differentiation
- 9.3 Landscape disruption
- Exhibit 89: Overview on factors of disruption
- 9.4 Industry risks
- Exhibit 90: Impact of key risks on business
10 Vendor Analysis
- 10.1 Vendors covered
- Exhibit 91: Vendors covered
- 10.2 Market positioning of vendors
- Exhibit 92: Matrix on vendor position and classification
- 10.3 Advanced Instruments LLC
- Exhibit 93: Advanced Instruments LLC - Overview
- Exhibit 94: Advanced Instruments LLC - Product / Service
- Exhibit 95: Advanced Instruments LLC - Key offerings
- 10.4 Boehringer Ingelheim International GmbH
- Exhibit 96: Boehringer Ingelheim International GmbH - Overview
- Exhibit 97: Boehringer Ingelheim International GmbH - Business segments
- Exhibit 98: Boehringer Ingelheim International GmbH - Key news
- Exhibit 99: Boehringer Ingelheim International GmbH - Key offerings
- Exhibit 100: Boehringer Ingelheim International GmbH - Segment focus
- 10.5 Eppendorf AG
- Exhibit 101: Eppendorf AG - Overview
- Exhibit 102: Eppendorf AG - Product / Service
- Exhibit 103: Eppendorf AG - Key news
- Exhibit 104: Eppendorf AG - Key offerings
- 10.6 Lonza Group Ltd.
- Exhibit 105: Lonza Group Ltd. - Overview
- Exhibit 106: Lonza Group Ltd. - Business segments
- Exhibit 107: Lonza Group Ltd. - Key news
- Exhibit 108: Lonza Group Ltd. - Key offerings
- Exhibit 109: Lonza Group Ltd. - Segment focus
- 10.7 Merck KGaA
- Exhibit 110: Merck KGaA - Overview
- Exhibit 111: Merck KGaA - Business segments
- Exhibit 112: Merck KGaA - Key news
- Exhibit 113: Merck KGaA - Key offerings
- Exhibit 114: Merck KGaA - Segment focus
- 10.8 Nova Biomedical Corp.
- Exhibit 115: Nova Biomedical Corp. - Overview
- Exhibit 116: Nova Biomedical Corp. - Product / Service
- Exhibit 117: Nova Biomedical Corp. - Key offerings
- 10.9 Repligen Corp.
- Exhibit 118: Repligen Corp. - Overview
- Exhibit 119: Repligen Corp. - Product / Service
- Exhibit 120: Repligen Corp. - Key news
- Exhibit 121: Repligen Corp. - Key offerings
- 10.10 Sartorius AG
- Exhibit 122: Sartorius AG - Overview
- Exhibit 123: Sartorius AG - Business segments
- Exhibit 124: Sartorius AG - Key news
- Exhibit 125: Sartorius AG - Key offerings
- Exhibit 126: Sartorius AG - Segment focus
- 10.11 Thermo Fisher Scientific Inc.
- Exhibit 127: Thermo Fisher Scientific Inc. - Overview
- Exhibit 128: Thermo Fisher Scientific Inc. - Business segments
- Exhibit 129: Thermo Fisher Scientific Inc. - Key news
- Exhibit 130: Thermo Fisher Scientific Inc. - Key offerings
- Exhibit 131: Thermo Fisher Scientific Inc. - Segment focus
- 10.12 Univercells SA
- Exhibit 132: Univercells SA - Overview
- Exhibit 133: Univercells SA - Product / Service
- Exhibit 134: Univercells SA - Key offerings
11 Appendix
- 11.2 Inclusions and exclusions checklist
- Exhibit 135: Inclusions checklist
- Exhibit 136: Exclusions checklist
- 11.3 Currency conversion rates for US$
- Exhibit 137: Currency conversion rates for US$
- 11.4 Research methodology
- Exhibit 138: Research methodology
- Exhibit 139: Validation techniques employed for market sizing
- Exhibit 140: Information sources
- 11.5 List of abbreviations
- Exhibit 141: List of abbreviations
About Technavio
Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.
With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
Contacts
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: [email protected]
Website: www.technavio.com/
SOURCE Technavio
Share this article